Depressive Disorder, Major: all 2,805 studies

Page 11 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.

• Oxytocin Add-on for Stable Depressed PatientsTerminatedNCT01211756Not applicableResults posted
• Treating Major Depression With Yoga: A Prospective, Randomized Controlled Pilot TrialCompletedNCT01210651Not applicableResults posted
• Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive DisorderCompletedNCT01198795Phase 4Results posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.CompletedNCT01197508Phase 3Results posted
• The Effectiveness of rTMS in Depressed VA PatientsCompletedNCT01191333Not applicableResults posted
• Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)CompletedNCT01190514Phase 1Results posted
• Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder SymptomsCompletedNCT01189812Phase 2Results posted
• A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) TreatmentCompletedNCT01187407Phase 3Results posted
• A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake InhibitorCompletedNCT01185340Phase 3Results posted
• Epigenetic Regulation of BDNF in Major DepressionCompletedNCT01182103Results posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCompletedNCT01180400Phase 3Results posted
• Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01179516Phase 3Results posted
• A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive DisorderCompletedNCT01173601Phase 3Results posted
• Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive DisorderCompletedNCT01168674Phase 4Results posted
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01163266Phase 3Results posted
• Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging StudyTerminatedNCT01162382Not applicableResults posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)CompletedNCT01157078Phase 3Results posted
• A Safety Study in Participants With Major Depressive DisorderCompletedNCT01155661Phase 3Results posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCompletedNCT01153347Phase 3Results posted
• Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01153009Phase 3Results posted
• Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension StudyCompletedNCT01152996Phase 3Results posted
• A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCompletedNCT01152554Phase 3Results posted
• Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.CompletedNCT01148979Phase 4Results posted
• 6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive DisorderTerminatedNCT01145755Phase 2Results posted
• Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in AdultsCompletedNCT01140906Phase 3Results posted
• A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)CompletedNCT01138007Phase 3Results posted
• Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic RegulationCompletedNCT01134731Phase 4Results posted
• To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01123707Phase 3Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)CompletedNCT01121484Phase 4Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111565Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111552Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111539Phase 3Results posted
• Pilot Study of Open-label Placebo to Treat Major Depressive DisorderCompletedNCT01103271Phase 2Results posted
• Rhodiola Rosea Therapy of Major Depressive DisorderCompletedNCT01098318Phase 3Results posted
• A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major DepressionTerminatedNCT01098240Phase 2Results posted
• Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive DisorderCompletedNCT01085812Phase 3Results posted
• A Study in Depression and Associated Painful Physical SymptomsCompletedNCT01070329Phase 4Results posted
• Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)CompletedNCT01056289Phase 4Results posted
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive DisorderCompletedNCT01052077Phase 2Results posted
• A Study of the Neurobiology of DepressionCompletedNCT01051466Phase 4Results posted
• Mindfulness Based Cognitive Therapy for Recurrent DepressionCompletedNCT01038765Not applicableResults posted
• Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort SyndromeCompletedNCT01035073Phase 4Results posted
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive DisorderCompletedNCT01034462Phase 3Results posted
• PET Biomarkers in Treatment Resistant DepressionTerminatedNCT01031810Phase 4Results posted
• fMRI Study of Treatment Changes in Major DepressionCompletedNCT01027559Not applicableResults posted
• AZD7268 Safety and Tolerability StudyCompletedNCT01020799Phase 2Results posted
• Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective AnalysisCompletedNCT01001559Results posted
• A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful SymptomsCompletedNCT01000805Phase 4Results posted
• This is a Study to Determine the Antidepressant Effects of AZD6765CompletedNCT00986479Phase 2Results posted
• SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive DisorderCompletedNCT00985725Phase 2Results posted
• A Study of Patients With Major Depressive Disorder and Residual ApathyCompletedNCT00985504Phase 4Results posted
• Clinical Study to Test a New Drug to Treat Major DepressionCompletedNCT00976560Phase 2Results posted
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive DisorderCompletedNCT00969709Phase 3Results posted
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive DisorderCompletedNCT00969150Phase 3Results posted
• Escitalopram (Lexapro) for Depression MS or ALSCompletedNCT00965497Phase 3Results posted
• The Role Of Omega-3 Fatty Acids In Adolescent DepressionCompletedNCT00962598Phase 2Results posted
• A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive DisorderCompletedNCT00960986Phase 4Results posted
• Study of 6(S)-5-MTHF Among Selective Serotonin Reuptake Inhibitor-Resistant Outpatients With Major Depressive DisorderCompletedNCT00955955Phase 4Results posted
• Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic SymptomsTerminatedNCT00955474Phase 4Results posted
• Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant DepressionCompletedNCT00953745Not applicableResults posted
• Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of MidazolamCompletedNCT00952653Phase 4Results posted
• Using a Text-message System to Engage Depressed Adolescents in Cognitive-behavioral Therapy HomeworkCompletedNCT00919932Not applicableResults posted
• Brain Imaging Techniques That Predict Antidepressant ResponsivenessCompletedNCT00909155Not applicableResults posted
• Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an AntidepressantCompletedNCT00905424Phase 2Results posted
• Safety and Efficacy Study in Patients With Major Depressive DisorderCompletedNCT00896363Phase 2Results posted
• Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive DisorderCompletedNCT00887224Phase 3Results posted
• Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00882362Phase 3Results posted
• A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive DisorderTerminatedNCT00880399Phase 2Results posted
• A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive DisorderTerminatedNCT00880048Phase 2Results posted
• Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00876343Phase 3Results posted
• Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety DisorderTerminatedNCT00868374Phase 3Results posted
• Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)CompletedNCT00866294Phase 3Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive DisorderCompletedNCT00863798Phase 3Results posted
• Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive DisorderCompletedNCT00854100Phase 2Results posted
• Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or EscitalopramCompletedNCT00851006Phase 2Results posted
• A Study in the Treatment of Children and Adolescents With Major Depressive DisorderCompletedNCT00849901Phase 3Results posted
• A Study in the Treatment of Children and Adolescents With Major Depressive DisorderCompletedNCT00849693Phase 3Results posted
• Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive DisorderCompletedNCT00844194Phase 4Results posted
• A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive DisorderCompletedNCT00840034Phase 2Results posted
• Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in AdultsCompletedNCT00839423Phase 2Results posted
• Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD)CompletedNCT00831415Phase 3Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive DisorderCompletedNCT00824291Phase 3Results posted
• Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in DepressionCompletedNCT00824044Phase 4Results posted
• Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly PatientsCompletedNCT00811252Phase 3Results posted
• Early Versus Delayed Switch in Medication in Patients With Major Depressive DisorderCompletedNCT00810069Phase 4Results posted
• Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive DisorderCompletedNCT00807248Phase 2Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive DisorderCompletedNCT00798707Phase 3Results posted
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderCompletedNCT00797966Phase 2Results posted
• A Study in Adult Patients With Major Depressive DisorderCompletedNCT00795821Phase 2/3Results posted
• Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD PatientsCompletedNCT00789854Phase 3Results posted
• A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.CompletedNCT00775203Phase 3Results posted
• Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD)CompletedNCT00770289Results posted
• Optimization of IV Ketamine for Treatment Resistant DepressionCompletedNCT00768430Phase 2Results posted
• Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in AdultsCompletedNCT00761306Phase 2Results posted
• Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)CompletedNCT00759395Phase 2Results posted
• Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed HispanicsCompletedNCT00742573Phase 2Results posted
• A Study of CX157 (TriRima) for the Treatment of DepressionCompletedNCT00739908Phase 2Results posted
• Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT00735709Phase 3Results posted
• A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive DisorderCompletedNCT00733980Phase 2Results posted
• Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)CompletedNCT00731653Phase 2Results posted

← Depressive Disorder, Major overview